Phase 1 randomized, parallel and pharmacokinetics study meloxicam and esomeprazole after single and multiple dose administration of AXS-06 in healthy volunteers.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 10 Oct 2018

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

16 Sep 2018 Results presented at the 17th World Congress on Pain
31 Jul 2017 New trial record
25 Jul 2017 Primary endpoint (time to maximum plasma concentration (Tmax) of meloxicam versus Mobic) has been met, according to an Axsome Therapeutics Media Release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com